Agenus Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.70. In total, the insiders bought 58 629 304 002 and sold 0 AGEN shares in the last 100 trades.

Insider Power

(Last 100 transactions)
99.70
Buy 5 862 930 Shares
Sell 0 Shares

Historical Insider Trades

Date Type Action Person Amount
Jul 01, 2024 Deferred Stock Units Buy Wright Timothy 776
Jul 01, 2024 Deferred Stock Units Buy Wiinberg Ulf 2 121
Jul 01, 2024 Deferred Stock Units Buy Hirsch Susan B 1 828
Jun 28, 2024 Common Stock Buy Armen Garo H 973
Jun 14, 2024 Common Stock Buy Armen Garo H 1 055
Jun 11, 2024 Common Stock Buy Buell Jennifer 0
Jun 11, 2024 Stock Option, right to buy Buy Buell Jennifer 37 500
Jun 11, 2024 Stock Option Buy O'day Steven J 37 907
Jun 11, 2024 Stock Option Buy O'day Steven J 10 000
Jun 11, 2024 Stock Option Buy Klaskin Christine M 10 642
Jun 11, 2024 Stock Option Buy Klaskin Christine M 6 250
Jun 11, 2024 Stock Option Buy Klaskin Christine M 3 125
Jun 11, 2024 Stock Option Buy Wright Timothy 750
Jun 11, 2024 Stock Option Buy Corvese Brian 750
Jun 11, 2024 Stock Option Buy Armen Garo H 108 000
Jun 11, 2024 Stock Option Buy Armen Garo H 65 651
May 31, 2024 Common Stock Buy Armen Garo H 1 040
May 17, 2024 Common Stock Buy Armen Garo H 1 502
May 03, 2024 Common Stock Buy Armen Garo H 1 248
Apr 19, 2024 Common Stock Buy Armen Garo H 3 080
Apr 05, 2024 Common Stock Buy Armen Garo H 32 697
Apr 01, 2024 Deferred Stock Units Buy Wright Timothy 14 135
Apr 01, 2024 Deferred Stock Units Buy Hirsch Susan B 32 039
Apr 01, 2024 Deferred Stock Units Buy Wiinberg Ulf 38 635
Mar 22, 2024 Common Stock Buy Armen Garo H 27 163
Click to get the best stock tips daily for free!

About Agenus Inc.

Agenus. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The... AGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT